Product Name

  • Name

    4-(PIPERIDIN-4-YL)-MORPHOLINE

  • EINECS 627-580-3
  • CAS No. 53617-35-9
  • Article Data18
  • CAS DataBase
  • Density 1.034 g/cm3
  • Solubility
  • Melting Point 40-43ºC
  • Formula C9H18N2O
  • Boiling Point 256.341 °C at 760 mmHg
  • Molecular Weight 170.255
  • Flash Point 108.832 °C
  • Transport Information
  • Appearance
  • Safety 26-36-36/37/39
  • Risk Codes  Xi:Irritant;
  • Molecular Structure Molecular Structure of 53617-35-9 (4-(PIPERIDIN-4-YL)-MORPHOLINE)
  • Hazard Symbols R36/37/38:;
  • Synonyms Morpholine,4-(4-piperidyl)- (7CI);4-(Morpholin-4-yl)piperidine;4-Morpholinopiperidine;
  • PSA 24.50000
  • LogP 1.94130

Synthetic route

4-(1-benzyl-piperidin-4-yl)-morpholine
415967-79-2

4-(1-benzyl-piperidin-4-yl)-morpholine

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

Conditions
ConditionsYield
With palladium on activated charcoal; hydrogen In isopropyl alcohol at 80℃; under 3750.38 Torr; for 7h; Reagent/catalyst; Autoclave;100%
With palladium on activated charcoal; hydrogen In methanol at 20℃; under 3750.38 Torr; for 6h;97.6%
With hydrogen; palladium 10% on activated carbon In methanol at 20℃; under 2585.81 Torr; for 18h;93%
With hydrogenchloride; Pd(OH)2 In methanol932 mg (91%)
With hydrogenchloride; Pd(OH)2 In methanol932 mg (91%)
4-(1-benzylpiperidin-4-yl)morpholine dihydrochloride

4-(1-benzylpiperidin-4-yl)morpholine dihydrochloride

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

Conditions
ConditionsYield
Stage #1: 4-(1-benzylpiperidin-4-yl)morpholine dihydrochloride With potassium carbonate In tert-butyl alcohol at 60℃; for 0.5h; pH=>11;
Stage #2: With palladium 10% on activated carbon In tert-butyl alcohol at 50℃; for 8h; pH=>11;
91.6%
Stage #1: 4-(1-benzylpiperidin-4-yl)morpholine dihydrochloride With potassium carbonate In water; tert-butyl alcohol at 45℃; Industrial scale;
Stage #2: With hydrogen In tert-butyl alcohol at 60℃; under 3000.3 Torr; Industrial scale;
88%
tert-butyl 4-(morpholin-4-yl)piperidine-1-carboxylate
125541-20-0

tert-butyl 4-(morpholin-4-yl)piperidine-1-carboxylate

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

Conditions
ConditionsYield
With trifluoroacetic acid In dichloromethane at 20℃; for 6h;79%
With trifluoroacetic acid In dichloromethane at 20℃; for 2h;
With hydrogenchloride In methanol at 40℃; for 12h;1.52 g
With trifluoroacetic acid In dichloromethane at 20℃;3 g
morpholine
110-91-8

morpholine

1-phenylmethyl-4-piperidone
3612-20-2

1-phenylmethyl-4-piperidone

A

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

B

4-(1-benzyl-piperidin-4-yl)-morpholine
415967-79-2

4-(1-benzyl-piperidin-4-yl)-morpholine

Conditions
ConditionsYield
With 10 wt% Pd(OH)2 on carbon; hydrogen at 80℃; under 3750.38 Torr; for 4h; Reagent/catalyst; Time; Autoclave;A 19.7%
B 77.5%
morpholine
110-91-8

morpholine

N-tert-butyloxycarbonylpiperidin-4-one
79099-07-3

N-tert-butyloxycarbonylpiperidin-4-one

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

Conditions
ConditionsYield
With sodium tris(acetoxy)borohydride; acetic acid In dichloromethane at 0 - 20℃; for 16h;74%
With sodium tris(acetoxy)borohydride; acetic acid In dichloromethane at 0 - 20℃; for 16h;74%
Stage #1: morpholine; N-tert-butyloxycarbonylpiperidin-4-one With titanium(IV) isopropylate In tetrahydrofuran at 20℃; for 1h;
Stage #2: With sodium cyanoborohydride In tetrahydrofuran; ethanol at 20℃;
Stage #3: With water In tetrahydrofuran; ethanol for 0.5h;
4-morpholinopyridine
2767-91-1

4-morpholinopyridine

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

Conditions
ConditionsYield
With hydrogen; ruthenium(IV) oxide
morpholine
110-91-8

morpholine

isopropyl alcohol
67-63-0

isopropyl alcohol

N-ethoxycarbonyl-4-piperidone
29976-53-2

N-ethoxycarbonyl-4-piperidone

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

Conditions
ConditionsYield
With potassium hydroxide; sodium borohydrid; toluene-4-sulfonic acid In ethanol; toluene
4-(4-morpholinopiperidin-1-yl)benzonitrile
186650-77-1

4-(4-morpholinopiperidin-1-yl)benzonitrile

A

4-fluorobenzonitrile
1194-02-1

4-fluorobenzonitrile

B

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

benzyl 4-morpholin-4-ylpiperidine-1-carboxylate
334942-09-5

benzyl 4-morpholin-4-ylpiperidine-1-carboxylate

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

Conditions
ConditionsYield
With hydrogen
1-phenylmethyl-4-piperidone
3612-20-2

1-phenylmethyl-4-piperidone

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: toluene / 110 °C / Industrial scale
1.2: Raney nickel / 60 °C / 3000.3 Torr / Industrial scale
1.3: 50 °C / Industrial scale
2.1: potassium carbonate / water; tert-butyl alcohol / 45 °C / Industrial scale
2.2: 60 °C / 3000.3 Torr / Industrial scale
View Scheme
Multi-step reaction with 2 steps
1: hydrogen; platinum on activated charcoal / 8 h / 80 °C / 3750.38 Torr / Autoclave
2: hydrogen; palladium on activated charcoal / isopropyl alcohol / 7 h / 80 °C / 3750.38 Torr / Autoclave
View Scheme
Multi-step reaction with 2 steps
1: sodium tris(acetoxy)borohydride; acetic acid / dichloromethane / 3 h / 20 °C
2: palladium on activated charcoal; hydrogen / methanol / 6 h / 20 °C / 3750.38 Torr
View Scheme
N-tert-butyloxycarbonylpiperidin-4-one
79099-07-3

N-tert-butyloxycarbonylpiperidin-4-one

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: palladium 10% on activated carbon; hydrogen / methanol
2: trifluoroacetic acid / dichloromethane / 2 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: acetic acid; sodium tris(acetoxy)borohydride / dichloromethane / 2 h / 20 °C / Cooling
2: trifluoroacetic acid / dichloromethane / 6 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: acetic acid; sodium tris(acetoxy)borohydride / dichloromethane / 16 h / 0 - 20 °C
2: hydrogenchloride / methanol / 12 h / 40 °C
View Scheme
Multi-step reaction with 2 steps
1.1: acetic acid / 1,2-dichloro-ethane / 0.17 h / 20 °C
1.2: 20 °C
2.1: trifluoroacetic acid / dichloromethane / 20 °C
View Scheme
4-HYDROXYPIPERIDINE
5382-16-1

4-HYDROXYPIPERIDINE

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: sodium hydroxide; water / 1,4-dioxane / 0 - 20 °C
2.1: pyridinium chlorochromate; SiO2 / dichloromethane / 2 h / 20 °C
3.1: acetic acid / 1,2-dichloro-ethane / 0.17 h / 20 °C
3.2: 20 °C
4.1: trifluoroacetic acid / dichloromethane / 20 °C
View Scheme
t-butyl 4-hydroxy piperidine-1-carboxylate
109384-19-2

t-butyl 4-hydroxy piperidine-1-carboxylate

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: pyridinium chlorochromate; SiO2 / dichloromethane / 2 h / 20 °C
2.1: acetic acid / 1,2-dichloro-ethane / 0.17 h / 20 °C
2.2: 20 °C
3.1: trifluoroacetic acid / dichloromethane / 20 °C
View Scheme
benzyl 4-oxo-1-piperidinecarboxylate
19099-93-5

benzyl 4-oxo-1-piperidinecarboxylate

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: titanium(IV) isopropylate
2: hydrogen
View Scheme
5-(3-benzofuran-2-yl-phenyl)-1,4-dimethyl-1H-pyrazole-3-carboxylic acid
1107658-97-8

5-(3-benzofuran-2-yl-phenyl)-1,4-dimethyl-1H-pyrazole-3-carboxylic acid

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

[5-(3-Benzofuran-2-yl-phenyl)-1,4-dimethyl-1H-pyrazol-3-yl]-(4-morpholin-4-yl-piperidin-1-yl)-methanone
1107656-39-2

[5-(3-Benzofuran-2-yl-phenyl)-1,4-dimethyl-1H-pyrazol-3-yl]-(4-morpholin-4-yl-piperidin-1-yl)-methanone

Conditions
ConditionsYield
Stage #1: 5-(3-benzofuran-2-yl-phenyl)-1,4-dimethyl-1H-pyrazole-3-carboxylic acid With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 20℃; for 1h;
Stage #2: 4-(piperidin-4-yl)morpholine With triethylamine In dichloromethane at 0℃; for 3h;
100%
potassium (chloromethyl)trifluoroborate

potassium (chloromethyl)trifluoroborate

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

C10H19BF3N2O(1-)*H(1+)

C10H19BF3N2O(1-)*H(1+)

Conditions
ConditionsYield
In tert-Amyl alcohol at 110℃; Inert atmosphere;100%
trifluoroacetic acid
76-05-1

trifluoroacetic acid

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

4-piperidin-4-yl-morpholine bis-trifluoroacetate
436099-97-7

4-piperidin-4-yl-morpholine bis-trifluoroacetate

Conditions
ConditionsYield
In dichloromethane at 20℃; for 1h;98%
trifluoro-methane sulfonic acid 9-bromo-3-cyano-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazol-8-yl ester
1256579-48-2

trifluoro-methane sulfonic acid 9-bromo-3-cyano-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazol-8-yl ester

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

6,6-dimethyl-9-bromo-8-[4-(morpholin-4-yl)piperidin-1-yl]-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
1256579-62-0

6,6-dimethyl-9-bromo-8-[4-(morpholin-4-yl)piperidin-1-yl]-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile

Conditions
ConditionsYield
In 1-methyl-pyrrolidin-2-one at 120℃; for 3h;98%
With N-methylcyclohexylamine at 80 - 90℃; Temperature; Reagent/catalyst; Large scale;78.6%
1,1-dimethyl-6-ethyl-1,2,3,4-tetrahydro-2-oxo-7-naphthyltriflate

1,1-dimethyl-6-ethyl-1,2,3,4-tetrahydro-2-oxo-7-naphthyltriflate

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

1,1-dimethyl-6-ethyl-7-[4-(morpholin-4-yl)piperidine-1-yl]-3,4-dihydro-2-naphthalenone

1,1-dimethyl-6-ethyl-7-[4-(morpholin-4-yl)piperidine-1-yl]-3,4-dihydro-2-naphthalenone

Conditions
ConditionsYield
With sodium methylate In 1,4-dioxane at 90℃; for 18h; Solvent; Temperature; Reagent/catalyst;97%
methyl 3-(bromomethyl)-6-chloro-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate
1336964-71-6

methyl 3-(bromomethyl)-6-chloro-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

methyl 6-chloro-3-{[4-(4-morpholinyl)-1-piperidinyl]methyl}-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate
1336964-72-7

methyl 6-chloro-3-{[4-(4-morpholinyl)-1-piperidinyl]methyl}-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate

Conditions
ConditionsYield
Stage #1: 4-(piperidin-4-yl)morpholine With potassium carbonate In dichloromethane at 20℃; for 0.5h;
Stage #2: methyl 3-(bromomethyl)-6-chloro-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate In dichloromethane at 20℃; for 24h;
96%
5-[(ethoxycarbonyl)methyl]-2-ethylphenyl trifluoromethanesulfonate

5-[(ethoxycarbonyl)methyl]-2-ethylphenyl trifluoromethanesulfonate

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

2-{4-ethyl-3-[4-(morpholin-4-yl)piperidin-1-yl]phenyl}acetate

2-{4-ethyl-3-[4-(morpholin-4-yl)piperidin-1-yl]phenyl}acetate

Conditions
ConditionsYield
With sodium methylate In N,N-dimethyl-formamide at 100℃; for 12h; Concentration; Temperature; Reagent/catalyst; Solvent; Green chemistry;96%
4-(8-(bromomethyl)-2-chloro-9-methyl-9H-purin-6-yl)morpholine
1257295-04-7

4-(8-(bromomethyl)-2-chloro-9-methyl-9H-purin-6-yl)morpholine

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

4-(1-((2-chloro-9-methyl-6-morpholino-9H-purin-8-yl)methyl)piperidin-4-yl)morpholine
1257296-26-6

4-(1-((2-chloro-9-methyl-6-morpholino-9H-purin-8-yl)methyl)piperidin-4-yl)morpholine

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 18h;95%
methyl 3-(bromomethyl)-7-[(2-methylpropyl)oxy]-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate
1336904-99-4

methyl 3-(bromomethyl)-7-[(2-methylpropyl)oxy]-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

methyl 7-[(2-methylpropyl)oxy]-3-{[4-(4-morpholinyl)-1-piperidinyl]methyl}-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate
1336966-25-6

methyl 7-[(2-methylpropyl)oxy]-3-{[4-(4-morpholinyl)-1-piperidinyl]methyl}-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 3h;95%
formaldehyd
50-00-0

formaldehyd

2-cyano-6-hydroxybenzothiazole
939-69-5

2-cyano-6-hydroxybenzothiazole

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

6-hydroxy-7-[[4-(morpholin-4-yl)piperidin-1-yl]methyl]-1,3-benzothiazole-2-carbonitrile

6-hydroxy-7-[[4-(morpholin-4-yl)piperidin-1-yl]methyl]-1,3-benzothiazole-2-carbonitrile

Conditions
ConditionsYield
Stage #1: formaldehyd; 4-(piperidin-4-yl)morpholine In acetonitrile at 80℃; for 1h;
Stage #2: 2-cyano-6-hydroxybenzothiazole In acetonitrile at 80℃;
95%
5-[2-(ethoxycarbonyl)propan-2-yl]-2-ethylphenyl trifluoromethanesulfonate

5-[2-(ethoxycarbonyl)propan-2-yl]-2-ethylphenyl trifluoromethanesulfonate

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

ethyl 2-{4-ethyl-3-[4-(morpholine-4-yl)piperidine-1-yl]phenyl}-2-methylpropionate

ethyl 2-{4-ethyl-3-[4-(morpholine-4-yl)piperidine-1-yl]phenyl}-2-methylpropionate

Conditions
ConditionsYield
With sodium t-butanolate In toluene at 90℃; for 18h; Solvent; Temperature; Reagent/catalyst;95%
7-benzyl-2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine

7-benzyl-2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

4-(1-(7-benzyl-2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl)morpholine

4-(1-(7-benzyl-2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl)morpholine

Conditions
ConditionsYield
With triethylamine In ethanol at 80℃; for 0.25h; Microwave irradiation; Sealed tube;95%
4-(2-(2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)ethyl)morpholine

4-(2-(2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)ethyl)morpholine

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

4-(2-(2-chloro-4-(4-morpholinopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)ethyl)morpholine

4-(2-(2-chloro-4-(4-morpholinopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)ethyl)morpholine

Conditions
ConditionsYield
With triethylamine In ethanol at 80℃; for 0.25h; Microwave irradiation;95%
1-[4-(2-bromoethyl)phenyl]ethanone
40422-73-9

1-[4-(2-bromoethyl)phenyl]ethanone

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

4-acetyl-2-(4-morpholin-4-yl-1-piperidinyl)-1-ethylbenzene

4-acetyl-2-(4-morpholin-4-yl-1-piperidinyl)-1-ethylbenzene

Conditions
ConditionsYield
With potassium tert-butylate In dimethyl sulfoxide at 5 - 80℃; Microwave irradiation;94.9%
4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidine-1-carboxylic acid (R)-2-(4-benzyloxy-3,5-dimethyl-phenyl)-1-carboxy-ethyl ester
866087-24-3

4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidine-1-carboxylic acid (R)-2-(4-benzyloxy-3,5-dimethyl-phenyl)-1-carboxy-ethyl ester

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

2-oxoethyl (1R)-4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-[[3,5-dimethyl-4-(phenylmethoxy)phenyl]methyl]-2-[4-(4-morpholinyl)-1-piperidinyl]-1-piperidinecarboxylate

2-oxoethyl (1R)-4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-[[3,5-dimethyl-4-(phenylmethoxy)phenyl]methyl]-2-[4-(4-morpholinyl)-1-piperidinyl]-1-piperidinecarboxylate

Conditions
ConditionsYield
With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide; triethylamine In tetrahydrofuran; ethyl acetate at 0 - 20℃; for 1h;94%
3-[8-(2,6-difluorophenyl)-2-(methylsulfinyl)-7-oxo-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-4-yl]-4-methyl-N-(1-methylethyl)benzamide
911693-62-4

3-[8-(2,6-difluorophenyl)-2-(methylsulfinyl)-7-oxo-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-4-yl]-4-methyl-N-(1-methylethyl)benzamide

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

3-{8-(2,6-difluorophenyl)-2-[4-(4-morpholinyl)-1-piperidinyl]-7-oxo-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-4-yl}-4-methyl-N-(1-methylethyl)benzamide

3-{8-(2,6-difluorophenyl)-2-[4-(4-morpholinyl)-1-piperidinyl]-7-oxo-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-4-yl}-4-methyl-N-(1-methylethyl)benzamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In tetrahydrofuran; chloroform at 20℃;94%
With N-ethyl-N,N-diisopropylamine In tetrahydrofuran; chloroform at 20℃;94%
1,1-dimethyl-3,4-dihydro-6-ethyl-7-bromonaphthalen-2-one

1,1-dimethyl-3,4-dihydro-6-ethyl-7-bromonaphthalen-2-one

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

1,1-dimethyl-6-ethyl-7-[4-(morpholin-4-yl)piperidine-1-yl]-3,4-dihydro-2-naphthalenone

1,1-dimethyl-6-ethyl-7-[4-(morpholin-4-yl)piperidine-1-yl]-3,4-dihydro-2-naphthalenone

Conditions
ConditionsYield
With sodium methylate In N,N-dimethyl-formamide at 100℃; for 8h; Reagent/catalyst; Solvent; Temperature;92.3%
1-bromomethyl-4-bromobenzene
589-15-1

1-bromomethyl-4-bromobenzene

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

4-(1-(4-bromobenzyl)piperidin-4-yl)morpholine
496775-18-9

4-(1-(4-bromobenzyl)piperidin-4-yl)morpholine

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 20℃; for 44h;92%
9-ethyl-8-iodo-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]-carbazole-3-carbonitrile

9-ethyl-8-iodo-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]-carbazole-3-carbonitrile

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

CH5424802
1256580-46-7

CH5424802

Conditions
ConditionsYield
With sodium methylate In N,N-dimethyl-formamide at 100℃; for 12h; Reagent/catalyst; Temperature;92%
With sodium methylate In toluene at 100℃; for 10h; Reagent/catalyst; Solvent;89%
With potassium tert-butylate; L-proline In 1,4-dioxane at 120℃; for 24h; Reagent/catalyst; Solvent; Temperature; Inert atmosphere;10.3 g
6-((3-fluorobenzyl)amino)imidazo[1,2-b]pyridazine-3-carboxylic acid

6-((3-fluorobenzyl)amino)imidazo[1,2-b]pyridazine-3-carboxylic acid

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

(6-((3-fluorobenzyl)amino)imidazo[1,2-b]pyridazin-3-yl)(4-morpholinopiperidin-1-yl)methanone

(6-((3-fluorobenzyl)amino)imidazo[1,2-b]pyridazin-3-yl)(4-morpholinopiperidin-1-yl)methanone

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 60℃; for 1h;91.39%
tert-butyl 4-(4-ethyl-3-iodo-phenyl)-4-methyl-3-oxo-pentanoate

tert-butyl 4-(4-ethyl-3-iodo-phenyl)-4-methyl-3-oxo-pentanoate

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

tert-butyl 4-{4-ethyl-3-[4-(morpholin-4-yl)piperidin-1-yl]phenyl}-4-methyl-3-oxopentanoate

tert-butyl 4-{4-ethyl-3-[4-(morpholin-4-yl)piperidin-1-yl]phenyl}-4-methyl-3-oxopentanoate

Conditions
ConditionsYield
With sodium ethanolate In toluene at 110℃; for 6h; Reagent/catalyst; Solvent; Temperature;91%
With iron(III)-acetylacetonate; caesium carbonate; copper(II) oxide In N,N-dimethyl-formamide at 90℃; for 20h; Reagent/catalyst; Solvent; Temperature; Sealed tube; Inert atmosphere; Green chemistry;82%
6-ethyl-1,2,3,4-tetrahydro-2-oxo-7-naphthalyl trifluoromethanesulfonate

6-ethyl-1,2,3,4-tetrahydro-2-oxo-7-naphthalyl trifluoromethanesulfonate

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

6-ethyl-7-[4-(morpholin-4-yl)piperidin-1-yl]-3,4-dihydro-2-naphthalenone

6-ethyl-7-[4-(morpholin-4-yl)piperidin-1-yl]-3,4-dihydro-2-naphthalenone

Conditions
ConditionsYield
With sodium methylate In N,N-dimethyl-formamide at 100℃; for 8h; Solvent; Temperature; Reagent/catalyst;91%
methyl 3-(bromomethyl)-6-(trifluoromethyl)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate
1336965-10-6

methyl 3-(bromomethyl)-6-(trifluoromethyl)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

methyl 3-{[4-(4-morpholinyl)-1-piperidinyl]methyl}-6-(trifluoromethyl)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate
1336965-12-8

methyl 3-{[4-(4-morpholinyl)-1-piperidinyl]methyl}-6-(trifluoromethyl)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 5h; Reflux;90%
methyl 3-(bromomethyl)-6-chloro-7-(methyloxy)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate
1336965-98-0

methyl 3-(bromomethyl)-6-chloro-7-(methyloxy)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

methyl 6-chloro-7-(methyloxy)-3-{[4-(4-morpholinyl)-1-piperidinyl]methyl}-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate
1336965-99-1

methyl 6-chloro-7-(methyloxy)-3-{[4-(4-morpholinyl)-1-piperidinyl]methyl}-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate

Conditions
ConditionsYield
In acetonitrile at 20℃; for 3h;90%
6-ethyl-7-bromo-3,4-dihydro-2-naphthalenone

6-ethyl-7-bromo-3,4-dihydro-2-naphthalenone

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

6-ethyl-7-[4-(morpholin-4-yl)piperidin-1-yl]-3,4-dihydro-2-naphthalenone

6-ethyl-7-[4-(morpholin-4-yl)piperidin-1-yl]-3,4-dihydro-2-naphthalenone

Conditions
ConditionsYield
With sodium isopropylate In 1,4-dioxane at 90℃; for 12h; Temperature; Reagent/catalyst; Solvent;90%
(Z)-5-(3-phenoxybenzylidene)-2-(methylthio)-3H-imidazol-4(5H)-one

(Z)-5-(3-phenoxybenzylidene)-2-(methylthio)-3H-imidazol-4(5H)-one

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

(Z)-5-(3-phenoxybenzylidene)-2-(4-morpholinopiperidin-1-yl)imidazol-4(5H)-one hydrochloride

(Z)-5-(3-phenoxybenzylidene)-2-(4-morpholinopiperidin-1-yl)imidazol-4(5H)-one hydrochloride

Conditions
ConditionsYield
Stage #1: (Z)-5-(3-phenoxybenzylidene)-2-(methylthio)-3H-imidazol-4(5H)-one; 4-(piperidin-4-yl)morpholine at 120 - 130℃; for 0.25h;
Stage #2: In ethanol Reflux;
Stage #3: With hydrogenchloride
89.26%
1-bromo-3-{[(4-methoxybenzyl)oxy]methyl}benzene
1274038-52-6

1-bromo-3-{[(4-methoxybenzyl)oxy]methyl}benzene

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

4-[1-(3-{[(4-methoxybenzyl)oxy]methyl}phenyl)piperidin-4-yl]morpholine

4-[1-(3-{[(4-methoxybenzyl)oxy]methyl}phenyl)piperidin-4-yl]morpholine

Conditions
ConditionsYield
With tris-(dibenzylideneacetone)dipalladium(0); 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl; sodium t-butanolate In toluene at 100℃; for 1h; Buchwald-Hartwig Coupling; Inert atmosphere;89%
methyl 3-(bromomethyl)-6-(ethylsulfonyl)-7-(methyloxy)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate
1335116-56-7

methyl 3-(bromomethyl)-6-(ethylsulfonyl)-7-(methyloxy)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate

4-(piperidin-4-yl)morpholine
53617-35-9

4-(piperidin-4-yl)morpholine

methyl 6-(ethylsulfonyl)-7-(methyloxy)-3-{[4-(4-morpholinyl)-1-piperidinyl]methyl}-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate
1335116-59-0

methyl 6-(ethylsulfonyl)-7-(methyloxy)-3-{[4-(4-morpholinyl)-1-piperidinyl]methyl}-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxylate

Conditions
ConditionsYield
In acetonitrile at 20℃; for 3h;87%

4-(Piperidin-4-yl)morpholine Chemical Properties

Molecular Structure of 4-(PIPERIDIN-4-YL)-MORPHOLINE(53617-35-9):

IUPAC Name:4-piperidin-4-ylmorpholine
Molecular Formula:C9H18N2O
Molecular Weight:170.252020 g/mol
Melting Point:40-43 °C(lit.)
Density:1.033 g/cm3
Flash Point:108.8 °C
Enthalpy of Vaporization:49.39 kJ/mol
Boiling Point:256.3 °C at 760 mmHg
Vapour Pressure:0.0155 mmHg at 25 °C
Water Solubility:7.111e+005 mg/L at 25 °C
Synonyms of 4-(PIPERIDIN-4-YL)-MORPHOLINE(53617-35-9):
CHEMBRDG-BB 4004473;4-MORPHOLINOPIPERIDINE;AKOS BB-9182;TIMTEC-BB SBB010091;4-Morpholino-piperidin;4-(PIPERIDIN-4-YL)-MORPHOLINE >98%;4-MORPHOLINO-PIPERDINEDIHYDROCHLORIDE
Categories of 4-(PIPERIDIN-4-YL)-MORPHOLINE(53617-35-9):
Building Blocks;Heterocyclic Building Blocks;Piperidines

4-(Piperidin-4-yl)morpholine Safety Profile

Safety Information of 4-(PIPERIDIN-4-YL)-MORPHOLINE(53617-35-9):
Hazard Codes:Xi
Risk Statements:36/37/38
36/37/38:Irritating to eyes, respiratory system and skin
Safety Statements:26-36
26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
36:Wear suitable protective clothing
WGK Germany:3
Hazard Note:Irritant
Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View